Straits Times Index
3,314.14 +8.12 (+0.25%) S&P 500
5,464.62 -8.55 (-0.16%) Dow
39,150.33 +15.53 (+0.04%) Nasdaq
17,689.36 -32.24 (-0.18%) Bitcoin USD
60,888.20 -3,364.31 (-5.24%) CMC Crypto 200
1,260.99 -48.73 (-3.72%)
TMDX Jan 2025 90.000 put
| Previous close | 6.11 |
| Open | 6.11 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 90.00 |
| Expiry date | 2025-01-17 |
| Day's range | 6.11 - 6.11 |
| Contract range | N/A |
| Volume | |
| Open interest | 4 |
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that on June 18, 2024, TransMedics granted non-qualified stock options to purchase an aggregate of 1,002 shares of its common stock and an aggregate of 657 restricted stock units to 1 employee, each as a material inducement for the employee's entry into employment with TransMedics. The grants
ZacksTransMedics (TMDX) Just Reclaimed the 20-Day Moving Average
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
GuruFocus.comInsider Sale: Director Edward Basile Sells Shares of TransMedics Group Inc (TMDX)
Director Edward Basile of TransMedics Group Inc (NASDAQ:TMDX) sold 1,193 shares of the company on June 5, 2024, according to a recent SEC Filing.
